Compare Fuji Finance Indonesia Tbk. (FUJI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fuji Finance Indonesia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Fuji Finance Indonesia Tbk. trades at Rp216 (market cap 275.6B, 2M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.1× Fuji Finance Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 2M). Which is the better fit depends on your goals.
| FUJI | LABS | |
|---|---|---|
Market Cap | 275.6B | 576.7B |
Volume | 2M | 3.48M |
Lot | 20.02K | 34.82K |
Turnover | 435.51M | 522.79M |
Average Price | 217.53 | 150.13 |
Value | 435.51M | 522.79M |
Indicative Equilibrium Price | 216 | 148 |
Indicative Equilibrium Volume | 33 | 350 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fuji Finance Indonesia Tbk.
PT Fuji Finance Indonesia Tbk (Company) was established first with the name of PT Jaya FajarLeasing Pratama based on Notarial Deed of Kartini Muljadi S.H., No. 287 on September 211982, which was changed to Jaya Fuji Leasing Pratama on March 28, 1983, then on July 2018 the Company's name was changed to Fuji Finance Indonesia
Read more on FUJI →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
